Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asahi Kasei Acquires U.S.-based Device Maker TechniKrom; Seeks ¥18 Billion in Sales

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Asahi Kasei Medical, a unit of Japan's Asahi Kasei, has reached an agreement to fully acquire TechniKrom, a bioprocess equipment manufacturer, in a merger that the company hopes will spark growth between its filtering technology and the U.S. firm's bioprocess equipment systems for biopharmaceutical manufacturing materials, the Japanese parent company announced Feb. 16

You may also be interested in...



Asahi Kasei Medical To Double Virus Filter Production

Asahi Kasei Medical announced Jan. 30 a plan to double its production capacity for virus filters. The company will invest ¥2.5 billion and establish a second production line at its facility in Oita city by March 2010. Widely used in the pharmaceutical production process, the filters are able to deactivate HIV or hepatitis virus mixed in animal by-products used as pharmaceutical materials. According to the company, the demand from the U.S. and Europe has been increasing. (Click here for more - Japanese language

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1132356

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel